Wilbanks Smith & Thomas Asset Management’s Idexx Laboratories IDXX Stock Holding History

Wilbanks Smith & Thomas Asset Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$911K	Buy	1,687 +4	+0.2%	+$2.19K	0.03%	246
2023 Q4	$934K	Hold	1,683	–	–	0.03%	235
2023 Q3	$736K	Sell	1,683 -126	-7%	-$62.8K	0.03%	255
2023 Q2	$909K	Hold	1,809	–	–	0.03%	234
2023 Q1	$905K	Sell	1,809 -47	-3%	-$22.5K	0.03%	230
2022 Q4	$757K	Buy	+1,856	New	+$720K	0.03%	249
2022 Q2	–	Sell	-529	Closed	-$231K	–	496
2022 Q1	$231K	Sell	529 -117	-18%	-$61.5K	0.01%	455
2021 Q4	$425K	Sell	646 -38	-6%	-$23.9K	0.01%	352
2021 Q3	$425K	Buy	684 +175	+34%	+$118K	0.02%	333
2021 Q2	$321K	Buy	+509	New	+$281K	0.01%	380
2018 Q4	–	Sell	-573	Closed	-$143K	–	794
2018 Q3	$143K	Buy	+573	New	+$139K	0.01%	468

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wilbanks Smith & Thomas Asset Management's IDXX Position: Q1 2024 in Review

Wilbanks Smith & Thomas Asset Management increased its Idexx Laboratories (IDXX) stake by 0.24% in Q1 2024, buying an estimated $2.19K and bringing the position to 1,687 shares worth $911K. The position accounts for 0.03% of the portfolio, ranked #246.

Wilbanks Smith & Thomas Asset Management first reported a position in IDXX in Q3 2018 and has held it in 11 quarters since. The position peaked at $934K in Q4 2023. 1,149 funds tracked by Wall St. Rank hold IDXX as of Q1 2024.

Wilbanks Smith & Thomas Asset Management held 1,687 shares of Idexx Laboratories worth $911K as of Q1 2024.
Wilbanks Smith & Thomas Asset Management bought 4 Idexx Laboratories shares in Q1 2024, an estimated $2.19K.
Idexx Laboratories made up 0.03% of Wilbanks Smith & Thomas Asset Management's portfolio in Q1 2024, its #246 holding.
Wilbanks Smith & Thomas Asset Management first reported a position in Idexx Laboratories in Q3 2018 and has held it in 11 quarters since.
Wilbanks Smith & Thomas Asset Management's Idexx Laboratories position peaked at $934K in Q4 2023.
1,149 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2024.

Based on Wilbanks Smith & Thomas Asset Management's 13F filing for Q1 2024, filed 7 May 2024.